Avalon SteriTech
Strives to provide next-generation disinfection technology for public spaces.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $9.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
Avalon SteriTech specializes in next-generation cleaning, disinfection, and sterilization technologies designed for public spaces. The company serves a diverse range of clients, including hospitals, transportation hubs, and other high-traffic areas, ensuring a safe and sterile environment. Operating primarily in the healthcare and public safety markets, Avalon SteriTech utilizes advanced robotics and antimicrobial solutions to achieve maximum disinfection efficacy. Their flagship product, Whiz Gambit, has been recognized for its innovation and effectiveness, particularly during the COVID-19 pandemic. The business model revolves around selling and leasing disinfection robots and antimicrobial films, as well as providing ongoing maintenance and support services. Revenue is generated through direct sales, service contracts, and partnerships with organizations like Softbank. Avalon SteriTech's solutions are EMA and EPA approved, offering 100% safe disinfectants that provide long-lasting protection.
Keywords: disinfection, sterilization, robotics, antimicrobial, public safety, healthcare, Whiz Gambit, QAC disinfectant, high-touch surfaces, innovation.